Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 18 | 2025 | 92 | 6.440 |
Why?
|
| Device Removal | 19 | 2025 | 170 | 4.820 |
Why?
|
| Vena Cava, Inferior | 12 | 2022 | 140 | 3.710 |
Why?
|
| Pulmonary Embolism | 11 | 2025 | 235 | 2.810 |
Why?
|
| Carcinoma, Hepatocellular | 10 | 2026 | 455 | 2.680 |
Why?
|
| Liver Neoplasms | 11 | 2026 | 840 | 2.400 |
Why?
|
| Venous Thrombosis | 9 | 2025 | 265 | 2.210 |
Why?
|
| Chemoembolization, Therapeutic | 3 | 2026 | 40 | 2.050 |
Why?
|
| Prosthesis Implantation | 5 | 2020 | 134 | 1.990 |
Why?
|
| Embolization, Therapeutic | 11 | 2026 | 338 | 1.830 |
Why?
|
| Yttrium Radioisotopes | 9 | 2026 | 63 | 1.660 |
Why?
|
| Microwaves | 3 | 2026 | 44 | 1.590 |
Why?
|
| Cholangiocarcinoma | 4 | 2026 | 92 | 1.310 |
Why?
|
| Bile Duct Neoplasms | 4 | 2026 | 106 | 1.290 |
Why?
|
| Treatment Outcome | 35 | 2026 | 9806 | 1.140 |
Why?
|
| Catheter Ablation | 3 | 2026 | 388 | 1.040 |
Why?
|
| Radiography, Interventional | 10 | 2026 | 155 | 0.990 |
Why?
|
| Glass | 1 | 2026 | 26 | 0.950 |
Why?
|
| Ablation Techniques | 1 | 2026 | 51 | 0.920 |
Why?
|
| Retrospective Studies | 25 | 2026 | 11104 | 0.790 |
Why?
|
| Microspheres | 4 | 2026 | 99 | 0.730 |
Why?
|
| Liver Transplantation | 8 | 2026 | 1235 | 0.720 |
Why?
|
| Intensive Care Units | 1 | 2025 | 476 | 0.660 |
Why?
|
| Cholecystostomy | 1 | 2020 | 5 | 0.650 |
Why?
|
| Cholecystitis, Acute | 1 | 2020 | 11 | 0.640 |
Why?
|
| Radiopharmaceuticals | 3 | 2026 | 214 | 0.630 |
Why?
|
| Tumor Burden | 3 | 2026 | 330 | 0.630 |
Why?
|
| Foreign-Body Migration | 1 | 2020 | 32 | 0.620 |
Why?
|
| Time Factors | 12 | 2026 | 5586 | 0.620 |
Why?
|
| Phlebography | 7 | 2017 | 74 | 0.610 |
Why?
|
| Surgical Instruments | 1 | 2020 | 70 | 0.610 |
Why?
|
| Middle Aged | 33 | 2026 | 29642 | 0.590 |
Why?
|
| Prosthesis Design | 8 | 2019 | 310 | 0.590 |
Why?
|
| Aged | 24 | 2026 | 21986 | 0.570 |
Why?
|
| Renal Dialysis | 6 | 2007 | 357 | 0.570 |
Why?
|
| Aorta | 1 | 2020 | 277 | 0.570 |
Why?
|
| Hemorrhage | 1 | 2019 | 297 | 0.510 |
Why?
|
| Stents | 3 | 2013 | 442 | 0.510 |
Why?
|
| Necrosis | 3 | 2026 | 225 | 0.500 |
Why?
|
| Humans | 58 | 2026 | 98799 | 0.480 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 468 | 0.480 |
Why?
|
| Female | 36 | 2026 | 51997 | 0.470 |
Why?
|
| Jugular Veins | 2 | 2014 | 65 | 0.470 |
Why?
|
| Femoral Vein | 2 | 2014 | 43 | 0.460 |
Why?
|
| Male | 35 | 2026 | 47475 | 0.460 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2006 | 44 | 0.450 |
Why?
|
| Aged, 80 and over | 12 | 2025 | 7461 | 0.430 |
Why?
|
| Vena Cava, Superior | 3 | 2014 | 54 | 0.430 |
Why?
|
| Vascular Diseases | 2 | 2014 | 119 | 0.430 |
Why?
|
| Catheters, Indwelling | 4 | 2013 | 102 | 0.410 |
Why?
|
| Brachiocephalic Veins | 1 | 2014 | 30 | 0.410 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 403 | 0.410 |
Why?
|
| Catheterization, Central Venous | 3 | 2013 | 115 | 0.390 |
Why?
|
| Risk Factors | 6 | 2025 | 6295 | 0.340 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 71 | 0.330 |
Why?
|
| Embolic Protection Devices | 1 | 2011 | 9 | 0.330 |
Why?
|
| Iliac Vein | 1 | 2011 | 32 | 0.330 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2011 | 42 | 0.320 |
Why?
|
| Portal Vein | 2 | 2013 | 122 | 0.320 |
Why?
|
| Hepatic Artery | 3 | 2021 | 85 | 0.320 |
Why?
|
| Bariatric Surgery | 2 | 2011 | 218 | 0.320 |
Why?
|
| Computed Tomography Angiography | 2 | 2026 | 192 | 0.310 |
Why?
|
| Thrombectomy | 4 | 2022 | 265 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2026 | 2680 | 0.300 |
Why?
|
| Hepatic Duct, Common | 1 | 2009 | 10 | 0.300 |
Why?
|
| Biliary Fistula | 1 | 2009 | 12 | 0.300 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2007 | 74 | 0.300 |
Why?
|
| Angioplasty, Balloon | 2 | 2007 | 91 | 0.290 |
Why?
|
| Disease Progression | 1 | 2024 | 1621 | 0.290 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 178 | 0.270 |
Why?
|
| Anticoagulants | 5 | 2020 | 486 | 0.270 |
Why?
|
| Liver Cirrhosis | 2 | 2009 | 290 | 0.270 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 255 | 0.260 |
Why?
|
| Adult | 19 | 2024 | 29698 | 0.260 |
Why?
|
| Chicago | 3 | 2019 | 1520 | 0.250 |
Why?
|
| Arm | 1 | 2007 | 99 | 0.250 |
Why?
|
| Risk Assessment | 5 | 2025 | 2604 | 0.250 |
Why?
|
| Aneurysm, False | 3 | 2013 | 52 | 0.230 |
Why?
|
| Ischemia | 1 | 2007 | 263 | 0.230 |
Why?
|
| Thrombolytic Therapy | 3 | 2020 | 261 | 0.220 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 249 | 0.210 |
Why?
|
| Prosthesis Failure | 3 | 2014 | 118 | 0.210 |
Why?
|
| Postoperative Complications | 5 | 2013 | 2719 | 0.190 |
Why?
|
| Constriction, Pathologic | 5 | 2022 | 214 | 0.190 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 4049 | 0.180 |
Why?
|
| Hepatectomy | 1 | 2024 | 218 | 0.180 |
Why?
|
| Cholangiography | 2 | 2005 | 38 | 0.180 |
Why?
|
| Hospital Mortality | 1 | 2025 | 533 | 0.170 |
Why?
|
| Propensity Score | 1 | 2022 | 218 | 0.170 |
Why?
|
| Fistula | 1 | 2021 | 44 | 0.160 |
Why?
|
| Bile | 1 | 2001 | 60 | 0.160 |
Why?
|
| Tokyo | 1 | 2020 | 3 | 0.160 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 18 | 0.160 |
Why?
|
| Adolescent | 9 | 2021 | 10168 | 0.150 |
Why?
|
| Vascular Patency | 5 | 2022 | 124 | 0.150 |
Why?
|
| Catheterization | 3 | 2008 | 220 | 0.150 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 38 | 0.150 |
Why?
|
| Hypotension | 1 | 2020 | 78 | 0.150 |
Why?
|
| Brachytherapy | 1 | 2021 | 139 | 0.150 |
Why?
|
| Radiation Exposure | 1 | 2019 | 29 | 0.150 |
Why?
|
| Equipment Safety | 2 | 2011 | 29 | 0.150 |
Why?
|
| Mortality | 1 | 2020 | 160 | 0.140 |
Why?
|
| Renal Veins | 2 | 2017 | 28 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2019 | 129 | 0.140 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2023 | 68 | 0.140 |
Why?
|
| Radiation Dosage | 1 | 2019 | 233 | 0.140 |
Why?
|
| Radiography | 4 | 2013 | 763 | 0.140 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 161 | 0.130 |
Why?
|
| Young Adult | 5 | 2021 | 7598 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2020 | 991 | 0.120 |
Why?
|
| Pipecolic Acids | 2 | 2006 | 14 | 0.120 |
Why?
|
| Recurrence | 1 | 2020 | 1274 | 0.120 |
Why?
|
| Length of Stay | 1 | 2020 | 889 | 0.120 |
Why?
|
| Fluoroscopy | 1 | 2016 | 139 | 0.120 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2007 | 92 | 0.120 |
Why?
|
| Anastomosis, Surgical | 2 | 2009 | 291 | 0.110 |
Why?
|
| Thrombin | 2 | 2013 | 60 | 0.110 |
Why?
|
| Hemostatics | 2 | 2013 | 63 | 0.110 |
Why?
|
| Angioplasty | 2 | 2013 | 69 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2025 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2006 | 251 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2013 | 75 | 0.100 |
Why?
|
| Abdominal Injuries | 1 | 2013 | 51 | 0.090 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 38 | 0.090 |
Why?
|
| Foreign Bodies | 1 | 2013 | 62 | 0.090 |
Why?
|
| Endoleak | 1 | 2012 | 46 | 0.090 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 119 | 0.090 |
Why?
|
| Contraindications | 1 | 2011 | 66 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2011 | 818 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 128 | 0.080 |
Why?
|
| Child, Preschool | 5 | 2006 | 4053 | 0.080 |
Why?
|
| Survival Rate | 1 | 2014 | 2057 | 0.080 |
Why?
|
| Renal Artery | 1 | 2010 | 45 | 0.080 |
Why?
|
| Plasma | 2 | 2007 | 49 | 0.080 |
Why?
|
| Equipment Design | 1 | 2011 | 428 | 0.080 |
Why?
|
| Portal System | 1 | 2009 | 12 | 0.070 |
Why?
|
| Balloon Occlusion | 1 | 2009 | 29 | 0.070 |
Why?
|
| Liver Failure | 1 | 2009 | 72 | 0.070 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 107 | 0.070 |
Why?
|
| Contrast Media | 3 | 2013 | 1014 | 0.070 |
Why?
|
| Alloys | 1 | 2007 | 10 | 0.070 |
Why?
|
| Axillary Vein | 1 | 2007 | 5 | 0.070 |
Why?
|
| Nephrectomy | 1 | 2010 | 291 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2007 | 37 | 0.060 |
Why?
|
| Hemostasis | 1 | 2007 | 24 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2009 | 250 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2007 | 90 | 0.060 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2006 | 8 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2011 | 869 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2007 | 48 | 0.060 |
Why?
|
| Thrombosis | 2 | 2006 | 319 | 0.060 |
Why?
|
| Potassium | 5 | 1990 | 230 | 0.060 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2006 | 40 | 0.060 |
Why?
|
| Dilatation | 1 | 2006 | 47 | 0.060 |
Why?
|
| Prosthesis-Related Infections | 1 | 2007 | 65 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2006 | 96 | 0.060 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2006 | 5 | 0.060 |
Why?
|
| Mesenteric Arteries | 1 | 2006 | 30 | 0.060 |
Why?
|
| Bacteremia | 1 | 2007 | 110 | 0.060 |
Why?
|
| Angiography | 2 | 2021 | 195 | 0.060 |
Why?
|
| Microfluidics | 1 | 2006 | 60 | 0.060 |
Why?
|
| Spasm | 1 | 2005 | 17 | 0.060 |
Why?
|
| Nitroglycerin | 1 | 2005 | 24 | 0.060 |
Why?
|
| Graft Survival | 1 | 2009 | 999 | 0.060 |
Why?
|
| Punctures | 1 | 2005 | 29 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 133 | 0.050 |
Why?
|
| Biliary Tract Diseases | 1 | 2005 | 37 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 556 | 0.050 |
Why?
|
| Retreatment | 2 | 2021 | 106 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2024 | 65 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2024 | 33 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 288 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2386 | 0.050 |
Why?
|
| Research Design | 1 | 2007 | 652 | 0.050 |
Why?
|
| Venous Pressure | 1 | 2002 | 10 | 0.050 |
Why?
|
| Leiomyoma | 1 | 2005 | 225 | 0.040 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2001 | 26 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 885 | 0.040 |
Why?
|
| Uterine Neoplasms | 1 | 2005 | 289 | 0.040 |
Why?
|
| Catheterization, Peripheral | 1 | 2001 | 63 | 0.040 |
Why?
|
| Age Factors | 1 | 2005 | 1976 | 0.040 |
Why?
|
| Drainage | 1 | 2001 | 176 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2002 | 258 | 0.040 |
Why?
|
| Erythrocyte Membrane | 2 | 1990 | 61 | 0.040 |
Why?
|
| Erythrocytes | 2 | 1989 | 242 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2002 | 749 | 0.030 |
Why?
|
| Infant | 3 | 2013 | 3368 | 0.030 |
Why?
|
| Arginine | 2 | 2006 | 144 | 0.030 |
Why?
|
| Chlorides | 3 | 1989 | 102 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 1571 | 0.030 |
Why?
|
| Sulfonamides | 2 | 2006 | 352 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2005 | 107 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 142 | 0.020 |
Why?
|
| Child | 4 | 2006 | 7771 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 300 | 0.020 |
Why?
|
| Sodium | 2 | 1990 | 332 | 0.020 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1989 | 11 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Ion Channels | 1 | 1990 | 264 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1798 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1946 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 1989 | 158 | 0.020 |
Why?
|
| Hemofiltration | 1 | 2006 | 11 | 0.020 |
Why?
|
| Phospholipids | 1 | 2007 | 110 | 0.020 |
Why?
|
| Titrimetry | 1 | 2006 | 14 | 0.020 |
Why?
|
| Duodenum | 1 | 2007 | 113 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2007 | 153 | 0.020 |
Why?
|
| Radiology, Interventional | 1 | 2006 | 62 | 0.010 |
Why?
|
| Life Tables | 1 | 2005 | 46 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2799 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 403 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2005 | 49 | 0.010 |
Why?
|
| Ointments | 1 | 2005 | 10 | 0.010 |
Why?
|
| Gastric Bypass | 1 | 2007 | 121 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 66 | 0.010 |
Why?
|
| Femur | 1 | 2005 | 112 | 0.010 |
Why?
|
| Arteries | 1 | 2005 | 172 | 0.010 |
Why?
|
| Biological Transport | 3 | 1989 | 402 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 180 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1538 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 451 | 0.010 |
Why?
|
| Reoperation | 1 | 2005 | 730 | 0.010 |
Why?
|
| Phlebotomy | 1 | 2001 | 22 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 2001 | 37 | 0.010 |
Why?
|
| Veins | 1 | 2001 | 88 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 2556 | 0.010 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1989 | 3 | 0.010 |
Why?
|
| Methazolamide | 2 | 1989 | 3 | 0.010 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1989 | 17 | 0.010 |
Why?
|
| Sheep | 2 | 1990 | 204 | 0.010 |
Why?
|
| United States | 1 | 2013 | 8387 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2001 | 722 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1989 | 489 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1990 | 121 | 0.000 |
Why?
|
| Cations | 1 | 1989 | 29 | 0.000 |
Why?
|
| Electric Conductivity | 1 | 1989 | 142 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1989 | 93 | 0.000 |
Why?
|
| Permeability | 1 | 1989 | 145 | 0.000 |
Why?
|
| Hemoglobin SC Disease | 1 | 1989 | 1 | 0.000 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1989 | 4 | 0.000 |
Why?
|
| Water-Electrolyte Balance | 1 | 1989 | 70 | 0.000 |
Why?
|
| Dogs | 1 | 1990 | 642 | 0.000 |
Why?
|
| Membrane Potentials | 1 | 1990 | 410 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1989 | 385 | 0.000 |
Why?
|
| Bumetanide | 1 | 1988 | 5 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1988 | 98 | 0.000 |
Why?
|
| Ouabain | 1 | 1988 | 25 | 0.000 |
Why?
|
| Anions | 1 | 1988 | 33 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 167 | 0.000 |
Why?
|
| Furosemide | 1 | 1988 | 34 | 0.000 |
Why?
|
| Hemolysis | 1 | 1988 | 66 | 0.000 |
Why?
|
| Rabbits | 1 | 1989 | 582 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1989 | 945 | 0.000 |
Why?
|
| Kinetics | 1 | 1988 | 1478 | 0.000 |
Why?
|
| Calcium | 1 | 1989 | 1205 | 0.000 |
Why?
|
| Animals | 2 | 1990 | 29045 | 0.000 |
Why?
|